[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @ValueForAll1 value value posts on X about $cdxs, $lly, $irwd, $prqr the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::1373080695728398339/interactions)  - X Week XXXXX +364% - X Month XXXXX -XXXX% - X Months XXXXXX -XX% - X Year XXXXXXX +156% ### Mentions: XX [#](/creator/twitter::1373080695728398339/posts_active)  - X Week XX +71% - X Month XX +23% - X Months XX -XX% - X Year XXX +111% ### Followers: XXX [#](/creator/twitter::1373080695728398339/followers)  - X Week XXX +1.50% - X Month XXX +0.34% - X Months XXX +21% - X Year XXX -XXXX% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1373080695728398339/influencer_rank)  ### Social Influence [#](/creator/twitter::1373080695728398339/influence) --- **Social category influence** [stocks](/list/stocks) XXXXX% [countries](/list/countries) XXXX% [finance](/list/finance) XXXX% [exchanges](/list/exchanges) XXXX% **Social topic influence** [$cdxs](/topic/$cdxs) #1, [$lly](/topic/$lly) #91, [$irwd](/topic/$irwd) #4, [$prqr](/topic/$prqr) #6, [betting](/topic/betting) #959, [$alny](/topic/$alny) 2.04%, [$nvs](/topic/$nvs) 2.04%, [china](/topic/china) 2.04%, [india](/topic/india) 2.04%, [$bcrx](/topic/$bcrx) XXXX% **Top accounts mentioned or mentioned by** [@biochemyst1](/creator/undefined) [@jfais20](/creator/undefined) [@biohazard3737](/creator/undefined) [@richtrades100](/creator/undefined) [@pikacapital](/creator/undefined) [@bigpharmaguy](/creator/undefined) [@sanctuarybio](/creator/undefined) [@sagimet](/creator/undefined) [@krtlarson](/creator/undefined) [@immunitybio](/creator/undefined) [@beonemedicines](/creator/undefined) [@iovancebio](/creator/undefined) [@bristolmyers](/creator/undefined) [@jazzpharma](/creator/undefined) [@servierpharma](/creator/undefined) [@genetech](/creator/undefined) [@shikhajainmd](/creator/undefined) [@dredkim](/creator/undefined) [@oneiltrader](/creator/undefined) [@piratewaffle](/creator/undefined) **Top assets mentioned** [Eli Lilly and Company (LLY)](/topic/$lly) [Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny) [Novartis AG (NVS)](/topic/$nvs) [Amicus Therapeutics, Inc (FOLD)](/topic/$fold) [Arrowhead Research Corporation (ARWR)](/topic/$arwr) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [GSK plc (GSK)](/topic/$gsk) [AbbVie Inc (ABBV)](/topic/$abbv) ### Top Social Posts [#](/creator/twitter::1373080695728398339/posts) --- Top posts by engagements in the last XX hours "As of today the vast majority of building blocks (NQP) for siRNA drugs of e.g. $alny and $nvs is manufactured using hash chemicals with a lot of toxic waste primary in China and India. There should be a better way rooting for $cdxs" [X Link](https://x.com/ValueForAll1/status/1972086600210493741) [@ValueForAll1](/creator/x/ValueForAll1) 2025-09-27T23:50Z XXX followers, XXX engagements "$bcrx deal reminds me a bit of $irwd buy of VectivBio. Bet on phase X asset but no CVR used all upfront. And fat debt to finance all that. This ended up badly for $irwd. Not sure how this plays out for BCRX. I prefer $fold approach - pay a small option fee for flipping ph3 card" [X Link](https://x.com/ValueForAll1/status/1978063789254754647) [@ValueForAll1](/creator/x/ValueForAll1) 2025-10-14T11:42Z XXX followers, 2347 engagements "Some countries are way easier to get novel modality Phase X clinical trial approval for. E.g. $wve runs INHBE obesity trial in Moldova $arwr in New Zealand. $prqr naively applied in Netherlands and now in the dark" [X Link](https://x.com/ValueForAll1/status/1977371126683648038) [@ValueForAll1](/creator/x/ValueForAll1) 2025-10-12T13:49Z XXX followers, 1972 engagements "$tecx On April X 2025 Mcguire (BoD chair) sold 500k shares at $XXXX. The same day GOAT Timothy Springer bought 500k shares at $17.1" [X Link](https://x.com/ValueForAll1/status/1978459002947166516) [@ValueForAll1](/creator/x/ValueForAll1) 2025-10-15T13:52Z XXX followers, XXX engagements "If $bmy picks up preclinical Orbital for $1.5B in cash I don't see why $lly has to pay less for $prqr. Novel modalities should be valued appropriately" [X Link](https://x.com/ValueForAll1/status/1977038093523075377) [@ValueForAll1](/creator/x/ValueForAll1) 2025-10-11T15:46Z XXX followers, XXX engagements "$acet data this week is another signal that CAR-T in I&I is not if but when. Safety will be important of course. But COGS and manufacturing time will be super important. $fate and $ipsc are the best equipped to win on COGS. Fate is on a run Century is a sleeper" [X Link](https://x.com/ValueForAll1/status/1976038179527602487) [@ValueForAll1](/creator/x/ValueForAll1) 2025-10-08T21:33Z XXX followers, XXX engagements "$scyx was on their way to restore their minimum bid NASDAQ compliance but on Sep XX someone stopped that XX days restarted and today it was stopped by nonsense "sell the news". Execs are very naive here. Bought the dip. $gsk should just end this suffering with low-ball BO" [X Link](https://x.com/ValueForAll1/status/1973074331904450654) [@ValueForAll1](/creator/x/ValueForAll1) 2025-09-30T17:15Z XXX followers, XXX engagements "$lly: Sr. Principal Process Engineer - Oligonucleotides Lilly plans to build a new $XXX billion facility to manufacture active pharmaceutical ingredients in Texas $cdxs $bchmf" [X Link](https://x.com/ValueForAll1/status/1977108934621335659) [@ValueForAll1](/creator/x/ValueForAll1) 2025-10-11T20:27Z XXX followers, XXX engagements "$irwd Very likely it's the last month below $X. ACG presentations Abbvie Q3 earnings. Maybe something bigger" [X Link](https://x.com/ValueForAll1/status/1976040355175989392) [@ValueForAll1](/creator/x/ValueForAll1) 2025-10-08T21:41Z XXX followers, XXX engagements "$cdxs Finally waking up a bit. TIDES EU is in a month this webinar with Bachem looks interesting. Bachem is a one stop to $lly who are betting a lot on oligos for the upcoming decade" [X Link](https://x.com/ValueForAll1/status/1975408139643330975) [@ValueForAll1](/creator/x/ValueForAll1) 2025-10-07T03:49Z XXX followers, 1179 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@ValueForAll1 value
value posts on X about $cdxs, $lly, $irwd, $prqr the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXX +364%
- X Month XXXXX -XXXX%
- X Months XXXXXX -XX%
- X Year XXXXXXX +156%
Mentions: XX #
- X Week XX +71%
- X Month XX +23%
- X Months XX -XX%
- X Year XXX +111%
Followers: XXX #
- X Week XXX +1.50%
- X Month XXX +0.34%
- X Months XXX +21%
- X Year XXX -XXXX%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence stocks XXXXX% countries XXXX% finance XXXX% exchanges XXXX%
Social topic influence $cdxs #1, $lly #91, $irwd #4, $prqr #6, betting #959, $alny 2.04%, $nvs 2.04%, china 2.04%, india 2.04%, $bcrx XXXX%
Top accounts mentioned or mentioned by @biochemyst1 @jfais20 @biohazard3737 @richtrades100 @pikacapital @bigpharmaguy @sanctuarybio @sagimet @krtlarson @immunitybio @beonemedicines @iovancebio @bristolmyers @jazzpharma @servierpharma @genetech @shikhajainmd @dredkim @oneiltrader @piratewaffle
Top assets mentioned Eli Lilly and Company (LLY) Alnylam Pharmaceuticals, Inc. (ALNY) Novartis AG (NVS) Amicus Therapeutics, Inc (FOLD) Arrowhead Research Corporation (ARWR) Bristol-Myers Squibb Co (BMY) GSK plc (GSK) AbbVie Inc (ABBV)
Top Social Posts #
Top posts by engagements in the last XX hours
"As of today the vast majority of building blocks (NQP) for siRNA drugs of e.g. $alny and $nvs is manufactured using hash chemicals with a lot of toxic waste primary in China and India. There should be a better way rooting for $cdxs"
X Link @ValueForAll1 2025-09-27T23:50Z XXX followers, XXX engagements
"$bcrx deal reminds me a bit of $irwd buy of VectivBio. Bet on phase X asset but no CVR used all upfront. And fat debt to finance all that. This ended up badly for $irwd. Not sure how this plays out for BCRX. I prefer $fold approach - pay a small option fee for flipping ph3 card"
X Link @ValueForAll1 2025-10-14T11:42Z XXX followers, 2347 engagements
"Some countries are way easier to get novel modality Phase X clinical trial approval for. E.g. $wve runs INHBE obesity trial in Moldova $arwr in New Zealand. $prqr naively applied in Netherlands and now in the dark"
X Link @ValueForAll1 2025-10-12T13:49Z XXX followers, 1972 engagements
"$tecx On April X 2025 Mcguire (BoD chair) sold 500k shares at $XXXX. The same day GOAT Timothy Springer bought 500k shares at $17.1"
X Link @ValueForAll1 2025-10-15T13:52Z XXX followers, XXX engagements
"If $bmy picks up preclinical Orbital for $1.5B in cash I don't see why $lly has to pay less for $prqr. Novel modalities should be valued appropriately"
X Link @ValueForAll1 2025-10-11T15:46Z XXX followers, XXX engagements
"$acet data this week is another signal that CAR-T in I&I is not if but when. Safety will be important of course. But COGS and manufacturing time will be super important. $fate and $ipsc are the best equipped to win on COGS. Fate is on a run Century is a sleeper"
X Link @ValueForAll1 2025-10-08T21:33Z XXX followers, XXX engagements
"$scyx was on their way to restore their minimum bid NASDAQ compliance but on Sep XX someone stopped that XX days restarted and today it was stopped by nonsense "sell the news". Execs are very naive here. Bought the dip. $gsk should just end this suffering with low-ball BO"
X Link @ValueForAll1 2025-09-30T17:15Z XXX followers, XXX engagements
"$lly: Sr. Principal Process Engineer - Oligonucleotides Lilly plans to build a new $XXX billion facility to manufacture active pharmaceutical ingredients in Texas $cdxs $bchmf"
X Link @ValueForAll1 2025-10-11T20:27Z XXX followers, XXX engagements
"$irwd Very likely it's the last month below $X. ACG presentations Abbvie Q3 earnings. Maybe something bigger"
X Link @ValueForAll1 2025-10-08T21:41Z XXX followers, XXX engagements
"$cdxs Finally waking up a bit. TIDES EU is in a month this webinar with Bachem looks interesting. Bachem is a one stop to $lly who are betting a lot on oligos for the upcoming decade"
X Link @ValueForAll1 2025-10-07T03:49Z XXX followers, 1179 engagements